
About Procter & Gamble
Procter & Gamble is a publicly listed company based in United States founded in 1837 by William Procter and James Gamble. Provider of FMCG conglomerate products. The company has 923 employees. Procter & Gamble has completed 28 acquisitions, including Ambi Pur, Billie and Braun. Its chief executive, as recorded, is Kumar Venkatasubramanian. Its website pg.com draws about 2.4 million monthly visits. Its Indian entity Procter & Gamble Hygiene And Health Care Limited reported revenue of βΉ4,333 Cr. Procter & Gamble offers products and services including Consumer Brands and Household Products. Its focus areas include Consumer Goods, Home Care Products, Multi-Category and Beauty & Personal Care Products. Its competitors include Glossier, Function of Beauty and Maesa; 2 of its 3 listed competitors have raised funding.
Company details
Procter Gamble was established in 1837 in the United States as a manufacturer of fast-moving consumer goods. Operations focus on categories including baby care, feminine and family care, beauty, fabric and home care, health, and grooming. A portfolio of 65 brands, such as Tide, Pampers, and Gillette, is maintained. In 2022, annual revenues of 80.97 billion and net profit of 14.32 billion were recorded, with global distribution supported.
- Market Cap₹23,380 Cr
PGHH · NSE
- Share Price₹7,190.50
-0.17% today
- Revenue₹4,290 Cr
FY 2025-26 · +27.2% YoY
- EBITDA₹1,171 Cr
Margin 27.3%
- Net Profit₹854 Cr
FY 2025-26 · +34.1% YoY
- P/E (TTM)29.3x
P/B 30.8x
- ROE114.9%
ROCE 136.3%
- Latest Funding Round$148.12K (USD), Grant
Oct 2021
- InvestorsEuropean Union
& 2 more
- Employee Count923
- Investments & AcquisitionsAmbi Pur
& 27 more
Associated legal entities of Procter & Gamble
Procter & Gamble is associated with 3 registered companies on The Company Check; the primary company is Procter & Gamble Hygiene And Health Care Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Procter & Gamble Hygiene And Health Care Limited Listed CIN L24239MH1964PLC012971 | Active | 20 Jul 1964 | Mumbai, Maharashtra | ₹4,333 Cr | 316 | 10 | View details |
| Gillette Diversified Operations Private Limited CIN U74899MH1994PTC249186 | Active | 02 Dec 1994 | Mumbai, Maharashtra | ₹574 Cr | 4 | View details | |
| Procter & Gamble Home Products Private Limited CIN U24240MH1989PTC050398 | Active | 19 Jan 1989 | Mumbai, Maharashtra | ₹9,229 Cr | 2,012 | 8 | View details |
Products & Services of Procter & Gamble
Procter & Gamble offers a comprehensive portfolio of products and services, including Consumer Brands and Household Products.
Various products for daily personal hygiene and beauty needs
Items for cleaning and maintaining household environments
Apps and channels of Procter & Gamble
Procter & Gamble publishes 1 mobile app with over 5M+ downloads; its YouTube channel P&G (Procter & Gamble) has 15.3M subscribers and 30 videos.
Videos from Procter & Gamble
The most watched videos on Procter & Gamble's YouTube channel, P&G (Procter & Gamble) (15.3M subscribers). Click a video to play it here.
More on P&G (Procter & Gamble).
Funding Insights of Procter & Gamble
- Total Rounds 25
- Last Round Grant β $148,124
- First Round $2.06M
(Jun 2006)
- Investors Count 3
Latest 10 of 25 funding rounds of Procter Gamble with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $148,124 | Grant | β | β | |
| Jan 2021 | $170,621 | Grant | β | β | |
| May 2020 | $326,769 | Grant | β | β | |
| Apr 2020 | $324,360 | Grant | β | β | |
| Nov 2019 | $402,060 | Grant | β | β | |
| Sep 2019 | $510,354 | Grant | β | β | |
| Aug 2019 | $1.56M | Grant | β | β | |
| Jun 2019 | $578,396 | Grant | β | β | |
| Apr 2019 | $10,018 | Grant | β | β | |
| Jan 2019 | $402,060 | Grant | β | β |
3 investors in total: 3 institutional.
Investors in Procter & Gamble
Procter & Gamble has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Trian Partners and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment management and private equity are focused on multiple sectors. | trianpartners.com | New York, United States | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Administers health care and support for military personnel and operations. | health.mil | Falls Church, United States |
Investor details for Procter Gamble
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Procter & Gamble Hygiene And Health Care Limited (Procter & Gamble)
Procter & Gamble Hygiene And Health Care Limited is the primary company behind Procter & Gamble. The boards of the 3 registered companies of Procter & Gamble currently have 18 directors; the longest-serving is Sonali Dhawan, appointed in 2014. 65 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sonali Dhawan DIN 06808527 | Director | 07 May 2014 | 12 yrs 6 mo | Procter & Gamble Hygiene And Health Care Limited |
| Pramod Agarwal DIN 00066989 | Director | 08 May 2015 | 11 yrs 6 mo | Procter & Gamble Hygiene And Health Care Limited |
| Ghanashyam Hegde DIN 08054712 | Director | 09 May 2019 | 7 yrs 6 mo | Procter & Gamble Hygiene And Health Care Limited |
| Sangmitra Sawant DIN 08108376 | Director | 11 Mar 2020 | 6 yrs 8 mo | Procter & Gamble Home Products Private Limited |
| Chittranjan Dua DIN 00036080 | Director | 25 Aug 2020 | 6 yrs 2 mo | Procter & Gamble Hygiene And Health Care Limited |
| Krishnamurthy Narayanan Iyer DIN 01726564 | Director | 01 Dec 2020 | 5 yrs 11 mo | Procter & Gamble Hygiene And Health Care Limited |
| Sheetal Akshay Chaubal DIN 09129241 | Director | 31 Mar 2021 | 5 yrs 7 mo | Gillette Diversified Operations Private Limited |
| Gurcharan Das DIN 00100011 | Director | 23 Aug 2022 | 4 yrs 2 mo | Procter & Gamble Hygiene And Health Care Limited |
| Sai Ramana Ponugoti DIN 09761074 | Director | 10 Oct 2022 | 4 yrs 1 mo | Procter & Gamble Home Products Private Limited |
| Sidharth Choudhary DIN 10427859 | Director | 15 Dec 2023 | 2 yrs 10 mo | Gillette Diversified Operations Private Limited |
| Ashima Goyal DIN 00233635 | Director | 19 Mar 2024 | 2 yrs 7 mo | Procter & Gamble Hygiene And Health Care Limited |
| Venkatasubra Manian Kumar DIN 08144200 | Managing Director | 01 May 2024 | 2 yrs 6 mo | Procter & Gamble Hygiene And Health Care Limited |
| Rahul Gaur DIN 10802603 | Director | 08 Oct 2024 | 2 yrs 1 mo | Gillette Diversified Operations Private Limited |
| Sumit Kumar Rana DIN 10804040 | Director | 09 Oct 2024 | 2 yrs 1 mo | Procter & Gamble Home Products Private Limited |
| Jay Vijay Tharoor DIN 10804041 | Director | 09 Oct 2024 | 2 yrs 1 mo | Procter & Gamble Home Products Private Limited |
| Mukta Maheshwari DIN 10483090 | Director | 08 Jan 2025 | 1 yr 10 mo | Procter & Gamble Home Products Private Limited |
| Anuj Kulwantraj Pawa DIN 10931156 | Director | 29 Jan 2025 | 1 yr 9 mo | Procter & Gamble Home Products Private Limited |
| Siddhanth Sharma DIN 08108360 | Additional Director | 28 Jan 2026 | 9 mo | Procter & Gamble Home Products Private Limited |
People of Procter & Gamble
1265 people are tracked at Procter & Gamble (788 in leadership, 11 in board & advisors, 466 in team); the tracked headcount is 923.
| Name | Role | Group |
|---|---|---|
William Procter | Founder | Leadership |
James Gamble | Founder | Leadership |
Kumar Venkatasubramanian | CEO India | Leadership |
Eldon Cate | Media Director | Leadership |
Gianluca Branda | Vice President -europe Fabric Care Product Supply | Leadership |
Chad Wehrman - Cfe | Global Security Director - Na/global Governance And Operations | Leadership |
Emma Pretswell | Vice President Quality Assurance | Leadership |
Angarish Otta | Director, IT | Leadership |
Ping Hu | R&d Director Principal Scientist | Leadership |
Jessi Capone | Bounty Initiatives Engineering Director | Leadership |
Christine Chia | Brand Director, Sk-ii Super Premium | Leadership |
Beatrice Tessier | Brand Director Personal Care Europe | Leadership |
Marcello Puddu | R&d Senior Director New Product Platform And Pilot Plant Operations Fabric Care | Leadership |
Jeff Morris | Finance Director, Northeast Region Customer Team | Leadership |
Ranya Shamoon | Senior Vice-president, Baby Care Category Growth & Transformation | Leadership |
Valérie le Bris | Human Resources Director | Leadership |
Doug Melton | Vice President Global R&d/supply Chain - Breakthrough Product Innovation | Leadership |
Emma Adelman | Product Management Director - NA Grooming Retail Operations | Leadership |
Yoshiaki Kondo | Brand Director - Dish Care Design, Fabric&home Care Growthworks Innovation | Leadership |
Nick Montesano | Director, Walmart Category Management And Advisory | Leadership |
1245 more people are available in the full profile.
Complete people profiles for Procter & Gamble
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Procter & Gamble
Procter & Gamble is a publicly listed company on the NSE with ticker symbol PGHH in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Jul 2004
- Listed onNSE: PGHH
- Listed entityProcter & Gamble Hygiene & Health Care Ltd.
- Exchange sectorConsumer non-durables
- ISINUS7427181091
- Share price$153.04 (-0.1% on the day) · 2026-10-13
- Market capitalisation$355.46B
- Price to earnings23.1
- EPS (diluted, trailing year)$6.62
- Dividend yield2.8%
- Volume (last session)6,038,341
Financials of Procter & Gamble
Exchange-reported figures of Procter & Gamble Hygiene And Health Care Limited, the listed company behind Procter & Gamble (NSE: PGHH).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 4,290 | 3,374 | 4,206 | 3,918 | 3,901 | 3,574 | 3,002 |
| Revenue growth | +27.2% | - | +7.4% | +0.4% | +9.1% | +19.1% | - |
| EBITDA | 1,171 | 871 | 970 | 869 | 830 | 884 | 604 |
| EBITDA margin | +27.3% | +25.8% | +23.1% | +22.2% | +21.3% | +24.7% | +20.1% |
| Profit before tax | 1,167 | 862 | 939 | 839 | 790 | 870 | 594 |
| Net profit | 854 | 637 | 679 | 679 | 577 | 653 | 435 |
| Net profit margin | +19.9% | +18.9% | +16.2% | +17.3% | +14.8% | +18.3% | +14.5% |
| EPS (βΉ) | 263.86 | 196.12 | 207.95 | 208.92 | 177.37 | 200.80 | 133.42 |
| Balance sheet | |||||||
| Total assets | 869 | 856 | - | - | - | - | - |
| Net worth | 753 | 737 | - | - | - | - | - |
| Total debt | 0.87 | 2.32 | - | - | - | - | - |
| Cash & bank | 568 | 481 | - | - | - | - | - |
| Net working capital | 210 | 208 | - | - | - | - | - |
| Cash flow | |||||||
| Cash from operations | 924 | 598 | - | - | - | - | - |
| Cash from investing | 11.37 | (34.28) | - | - | - | - | - |
| Cash from financing | (845) | (671) | - | - | - | - | - |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 891 | 941 | 1,262 | 1,150 | 937 | 992 | 1,248 | 1,135 |
| Revenue growth (YoY) | -4.9% | -5.1% | +1.1% | +1.3% | +0.6% | - | - | - |
| Other income | 9.43 | 12.47 | 12.41 | 9.90 | 7.69 | 19.13 | 9.71 | 8.50 |
| Total expenses | 721 | 723 | 860 | 865 | 671 | 782 | 877 | 845 |
| EBITDA | 170 | 218 | 402 | 285 | 266 | 210 | 371 | 290 |
| EBITDA margin | +19.1% | +23.3% | +31.9% | +24.8% | +28.5% | +21.2% | +29.8% | +25.6% |
| Depreciation | 9.59 | 9.56 | 9.50 | 9.28 | 9.09 | 10.35 | 9.89 | 11.70 |
| Interest | 0.27 | 3.11 | 2.67 | 3.60 | 0.07 | 5.77 | 6.62 | 1.91 |
| Profit before tax | 170 | 218 | 402 | 282 | 265 | 213 | 364 | 285 |
| Tax | 43.36 | 64.98 | 101 | 71.92 | 72.64 | 56.56 | 95.54 | 73.47 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 891 | 941 | 1,262 | 1,150 | 937 | 992 | 1,248 | 1,135 |
| Revenue growth (YoY) | -4.9% | -5.1% | +1.1% | +1.3% | +0.6% | - | - | - |
| Other income | 9.43 | 12.47 | 12.41 | 9.90 | 7.69 | 19.13 | 9.71 | 8.50 |
| Total expenses | 721 | 723 | 860 | 865 | 671 | 782 | 877 | 845 |
| EBITDA | 170 | 218 | 402 | 285 | 266 | 210 | 371 | 290 |
| EBITDA margin | +19.1% | +23.3% | +31.9% | +24.8% | +28.5% | +21.2% | +29.8% | +25.6% |
| Depreciation | 9.59 | 9.56 | 9.50 | 9.28 | 9.09 | 10.35 | 9.89 | 11.70 |
| Interest | 0.27 | 3.11 | 2.67 | 3.60 | 0.07 | 5.77 | 6.62 | 1.91 |
| Profit before tax | 170 | 218 | 402 | 282 | 265 | 213 | 364 | 285 |
| Tax | 43.36 | 64.98 | 101 | 71.92 | 72.64 | 56.56 | 95.54 | 73.47 |
| Particulars | FY 2025-26 | FY 2024-25 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,290 | 3,374 | 4,206 | 3,918 | 3,901 | 3,574 | 3,002 |
| Revenue growth | +27.2% | - | +7.4% | +0.4% | +9.1% | +19.1% | - |
| Other income | 42.47 | 37.34 | 52.25 | 40.58 | 24.32 | 39.38 | 44.11 |
| Total expenses | 3,119 | 2,503 | 3,235 | 3,049 | 3,071 | 2,690 | 2,398 |
| Employee cost | 215 | 176 | 246 | 206 | 214 | 202 | 173 |
| EBITDA | 1,171 | 871 | 970 | 869 | 830 | 884 | 604 |
| EBITDA margin | +27.3% | +25.8% | +23.1% | +22.2% | +21.3% | +24.7% | +20.1% |
| Depreciation | 37.43 | 31.94 | 56.50 | 58.36 | 52.88 | 47.66 | 47.88 |
| Interest | 9.45 | 14.30 | 27.00 | 11.38 | 11.19 | 6.11 | 6.07 |
| Profit before tax | 1,167 | 862 | 939 | 839 | 790 | 870 | 594 |
| Tax | 310 | 226 | 264 | 161 | 214 | 218 | 161 |
| Net profit | 854 | 637 | 679 | 679 | 577 | 653 | 435 |
| Net profit margin | +19.9% | +18.9% | +16.2% | +17.3% | +14.8% | +18.3% | +14.5% |
| EPS (βΉ) | 263.86 | 196.12 | 207.95 | 208.92 | 177.37 | 200.80 | 133.42 |
| Particulars | FY 2025-26 | FY 2024-25 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 32.46 | 32.46 | - | - | - | - | - |
| Reserves & surplus | 721 | 705 | - | - | - | - | - |
| Shareholders' funds (net worth) | 753 | 737 | - | - | - | - | - |
| Secured loans | 0.00 | 0.00 | - | - | - | - | - |
| Unsecured loans | 0.87 | 2.32 | - | - | - | - | - |
| Total debt | 0.87 | 2.32 | - | - | - | - | - |
| Total liabilities | 869 | 856 | - | - | - | - | - |
| Assets | |||||||
| Gross block | 558 | 547 | - | - | - | - | - |
| Net block | 163 | 131 | - | - | - | - | - |
| Capital work in progress | 21.27 | 40.71 | - | - | - | - | - |
| Investments | 0.00 | 0.00 | - | - | - | - | - |
| Inventories | 218 | 221 | - | - | - | - | - |
| Sundry debtors | 243 | 304 | - | - | - | - | - |
| Cash & bank balances | 568 | 481 | - | - | - | - | - |
| Loans & advances | 115 | 101 | - | - | - | - | - |
| Total current assets | 1,144 | 1,107 | - | - | - | - | - |
| Total current liabilities | 934 | 899 | - | - | - | - | - |
| Net working capital | 210 | 208 | - | - | - | - | - |
| Total assets | 869 | 856 | - | - | - | - | - |
| Particulars | FY 2025-26 | FY 2024-25 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|
| Opening cash | 466 | 574 | - | - | - | - | - |
| Net cash from operating activities | 924 | 598 | - | - | - | - | - |
| Net cash from investing activities | 11.37 | (34.28) | - | - | - | - | - |
| Net cash from financing activities | (845) | (671) | - | - | - | - | - |
| Net change in cash | 90.65 | (107) | - | - | - | - | - |
| Closing cash | 568 | 481 | - | - | - | - | - |
| Particulars | FY 2025-26 | FY 2024-25 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +27.2% | - | +7.4% | +0.4% | +9.1% | +19.1% | - |
| EBITDA growth | +34.4% | - | +11.7% | +4.7% | -6.2% | +46.5% | - |
| PBT growth | +35.3% | -8.2% | +11.9% | +6.2% | -9.2% | +46.5% | -2.2% |
| Net income growth | +34.1% | - | +0.0% | +17.6% | -11.7% | +50.2% | - |
| Revenue CAGR (3Y) | +3.1% | -4.7% | +5.6% | +9.3% | +9.8% | +13.3% | +9.0% |
| EBITDA CAGR (3Y) | +10.5% | +1.6% | +3.2% | +12.9% | +10.9% | +12.8% | -3.2% |
| Profitability & leverage | |||||||
| Net income margin | +20.0% | +18.9% | +16.1% | +17.3% | +14.8% | +18.2% | +14.4% |
| Return on capital employed | +136.4% | +102.4% | +99.8% | +90.4% | +98.5% | +86.1% | +54.3% |
| Return on net worth | +114.9% | +86.4% | +78.5% | +80.6% | +79.3% | +69.6% | +41.9% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.83 | 1.70 | 2.95 | 1.40 | 1.44 | 0.73 | 1.09 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 7.76 | 6.17 | 7.35 | 7.40 | 8.02 | 7.76 | 6.81 |
| Inventory turnover | 19.53 | 15.24 | 18.89 | 17.27 | 16.14 | 15.73 | 14.70 |
| Debtors turnover | 15.69 | 11.10 | 18.40 | 19.19 | 23.33 | 23.16 | 17.27 |
| EPS (βΉ) | 263.86 | 196.12 | 207.95 | 208.92 | 177.37 | 200.80 | 133.42 |
| Dividend per share (βΉ) | 255.00 | 175.00 | 255.00 | 185.00 | 160.00 | 315.00 | 105.00 |
| Book value per share (βΉ) | 232.12 | 227.05 | 238.71 | 291.44 | 227.22 | 220.05 | 356.70 |
Investments & Acquisitions by Procter & Gamble
Procter & Gamble has strategically engaged in corporate development activities, having acquired 28 companies. Notable acquisitions include Ambi Pur, Billie and Braun.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Antacid products for heartburn and indigestion are manufactured sustainably. | wonderbelly.com | Austin, United States | 2021 | Jan 2026 | β’β’β’β’ | |
brand of natural beauty & personal care products | mielleorganics.com | Crown Point, United States | 2014 | Jan 2023 | β’β’β’β’ | |
Private label skincare products for women are offered by TULA. | tula.com | New York, United States | 2014 | Jan 2022 | β’β’β’β’ | |
Provider of hair care, body, and fragrance products | theouai.com | Los Angeles, United States | 2015 | Dec 2021 | β’β’β’β’ | |
Natural skincare products are sold online by Farmacy Beauty. | farmacybeauty.com | New York, United States | 2015 | Nov 2021 | β’β’β’β’ | |
VÖOST is recognized for producing effervescent vitamin and mineral tablets. | voostvitamins.com | 0 | Apr 2021 | β’β’β’β’ | ||
Brand of hair removal products for women | mybillie.com | New York, United States | 2017 | Jan 2020 | β’β’β’β’ | |
Organic menstrual hygiene products are provided via an internet-first brand. | thisisl.com | San Francisco, United States | 2011 | Feb 2019 | β’β’β’β’ | |
Health and beauty products are tailored for people of color. | walkerandcompany.com | Palo Alto, United States | 2013 | Dec 2018 | β’β’β’β’ | |
Skincare products for sensitive skin are developed and offered. | firstaidbeauty.com | Boston, United States | 2008 | Jul 2018 | $250M |
Complete acquisition details for Procter Gamble
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Procter & Gamble
14 dated milestones of Procter & Gamble across 189 years, from founding to its latest funding, stage changes and deals.
- Founded Procter & Gamble is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $2.1M.
- Acquisition Acquires First Aid Beauty.
- Acquisition Acquires Walker & Company.
- Acquisition Acquires L. International.
- Acquisition Acquires Billie.
- Acquisition Acquires VÖOST.
- Funding Latest funding round, Grant, of $148K.
- Acquisition Acquires Farmacy Beauty.
- Acquisition Acquires OUAI Haircare.
- Acquisition Acquires TULA.
- Acquisition Acquires Mielle Organics.
- Acquisition Acquires Wonderbelly.
Competitors of Procter & Gamble
Procter & Gamble has 3 listed competitors in our database, 2 of them funded. They include Glossier, Function of Beauty and Maesa.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glossier.com | 2005 | New York, United States | $266.4M | 368 | Multicategory beauty products are offered via an internet-first brand. | |
| functionofbeauty.com | 2015 | New York, United States | $166.17M | 335 | Customized skin and hair care products are provided online. | |
| maesa.com | 1997 | New York, United States | 202 | Beauty products are manufactured for private labels and retailers. |
Detailed competitors of Procter Gamble
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Procter & Gamble
The website of Procter & Gamble (pg.com) receives about 2.4M visits a month and ranks #25,811 among all websites worldwide, #594 in Health.
- Monthly visits2.4M
▲ 9.6% vs previous month
- Unique visitors790.7K
per month
- Global rank#25,811
among all websites
- Category rank#594
Health · Health
- Bounce rate37%
- Pages per visit3.9
- Average visit3 min 58 sec
- DevicesDesktop 56% Β· Mobile 44%
Websites whose visitors overlap most with Procter & Gamble. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abbott.com | 100% | 917.2K | #65,577 | View details | |
| bms.com | 100% | 809.8K | #67,210 | View details | |
| gsk.com | 99% | 1.3M | #56,834 | View details | |
| indelpa.com.mx | 80% | View details | |||
| pfizer.com | 73% | 1.9M | #24,984 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 24 similar websites and full traffic analytics for Procter & Gamble
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Procter & Gamble (Beauty & Personal Care Products) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
3M is recognized as a global leader in industrial innovation. | 1902 | United States | USD 24.95 B | 74 | ||
Subscription-based men's grooming products are provided by Harry's. | 2012 | New York, New York, United States | USD 755.88 M | 431 | ||
Baby products from multiple retailers are aggregated and browsed online. | 2011 | Oakland, California, United States | USD 40.67 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Procter & Gamble
Complete news archive for Procter Gamble
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Procter & Gamble
Procter & Gamble was founded in 1837 and raised its 1st funding round 169 years after it was founded.
Procter & Gamble is headquartered in United States.
Kumar Venkatasubramanian is the CEO of Procter & Gamble, as recorded in our data.
Procter & Gamble has 923 employees.
The primary company behind Procter & Gamble, Procter & Gamble Hygiene And Health Care Limited, reported revenue of βΉ4,333 Cr for FY 2026, up 27% year on year.
Procter Gamble was established in 1837 in the United States as a manufacturer of fast-moving consumer goods. Operations focus on categories including baby care, feminine and family care, beauty, fabric and home care, health, and grooming. A portfolio of 65 brands, such as Tide, Pampers, and Gillette, is maintained. In 2022, annual revenues of 80.97 billion and net profit of 14.32 billion were recorded, with global distribution supported.
Procter & Gamble's top competitors include Glossier, Maesa and Function of Beauty.
Procter & Gamble offers Consumer Brands and Household Products.
Yes, Procter & Gamble is publicly traded on NSE under the ticker symbol PGHH.
Procter & Gamble has 3 investors. Key investors include European Union, Trian Partners, and Military Health.
Procter & Gamble is associated with 3 legal entities: Procter & Gamble Hygiene And Health Care Limited, Gillette Diversified Operations Private Limited, Procter & Gamble Home Products Private Limited.
